CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-03 | Sheena Jonathan Director | Sale 10b5-1 | −2,655 | $59.98 | $159K | 472,088 |
| 2024-01-03 | Sheena Jonathan Director | Sale 10b5-1 | −2,345 | $60.67 | $142K | 469,743 |
| 2024-01-03 | Sheena Jonathan Director | Sale 10b5-1 | −500 | $60.44 | $30K | 21,155 |
| 2024-01-03 | Sheena Jonathan Director | Sale 10b5-1 | −460 | $60.42 | $28K | 21,195 |
| 2024-01-03 | Sheena Jonathan Director | Sale 10b5-1 | −40 | $60.92 | $2K | 21,155 |
| 2023-12-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,377 | $62.29 | $86K | 64,810 |
| 2023-12-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −915 | $63.29 | $58K | 66,187 |
| 2023-12-28 | Chapman Steven Leonard CEO AND PRESIDENT | Sale | −2,604 | $63.29 | $165K | 172,348 |
| 2023-12-28 | Sheena Jonathan Director | Sale 10b5-1 | −134 | $63.29 | $8K | 475,056 |
| 2023-12-28 | Sheena Jonathan Director | Sale 10b5-1 | −313 | $62.07 | $19K | 474,743 |
| 2023-12-28 | Sheena Jonathan Director | Sale 10b5-1 | −500 | $62.13 | $31K | 21,655 |
| 2023-12-28 | Sheena Jonathan Director | Sale 10b5-1 | −500 | $62.11 | $31K | 21,655 |
| 2023-12-28 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale | −728 | $63.29 | $46K | 180,442 |
| 2023-12-27 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +2,292 | 67,102 | ||
| 2023-12-27 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −2,292 | 2,292 | ||
| 2023-12-27 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion | +5,183 | 174,952 | ||
| 2023-12-27 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Restricted Stock Unit | −5,183 | 5,184 | ||
| 2023-12-27 | Sheena Jonathan Director | Exercise or conversion 10b5-1 | +447 | 475,190 | ||
| 2023-12-27 | Sheena Jonathan Director | Exercise or conversion · Restricted Stock Unit 10b5-1 | −447 | 447 | ||
| 2023-12-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion | +1,363 | 181,170 |
Page 83 of 85 · 1,682 trades